Responses
Immunotherapy biomarkers
Original research
Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.